ArticleInternational journal of computer assisted radiology and surgery2025
Multimodal imaging platform for enhanced tumor resection in neurosurgery: integrating hyperspectral and pCLE technologies.
Article in International journal of computer assisted radiology and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Wide-field and non-invasive imaging of brain tumours with scattered light techniques.Biomedical optics express · 2026Article
- Artificial intelligence in neurovascular surgery: advancing diagnosis, treatment, and outcomes.Frontiers in surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeThis work presents a novel multimodal imaging platform that integrates hyperspectral imaging (HSI) and probe-based confocal laser endomicroscopy (pCLE) for improved brain tumor identification during neurosurgery. By combining these two modalities, we aim to enhance surgical navigation, addressing the limitations of using each modality when used independently.
methodsWe developed a multimodal imaging platform that integrates HSI and pCLE within an operating microscope setup using computer vision techniques. The system combines real-time, high-resolution HSI for macroscopic tissue analysis with pCLE for cellular-level imaging. The predictions of each modality made using Machine Learning methods are combined to improve tumor identification.
resultsOur evaluation of the multimodal system revealed low spatial error, with minimal reprojection discrepancies, ensuring precise alignment between the HSI and pCLE. This combined imaging approach together with our multimodal tissue characterization algorithm significantly improves tumor identification, yielding higher Dice and Recall scores compared to using HSI or pCLE individually.
conclusionOur multimodal imaging platform represents a crucial first step toward enhancing tumor identification by combining HSI and pCLE modalities for the first time. We highlight improvements in metrics such as the Dice score and Recall, underscoring the potential for further advancements in this area.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.